Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma

doi:10.3748/wjg.v26.i10.1042

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7862)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

364

WORD

195

HTML

3646

Figures (1-4)

348

Tables (1-4)

600

Sum=5153

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

789

Download

1920

Sum=2709

Mar 14, 2020 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Mar 14, 2020; 26(10): 1042-1055
Published online Mar 14, 2020. doi: 10.3748/wjg.v26.i10.1042

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curve for liver cancer survival in the low and high ferritin-to-hemoglobin ratio group. A: Low ferritin-to-hemoglobin ratio; B: High ferritin-to-hemoglobin ratio. PA-TACE: Postoperative adjuvant transcatheter arterial chemoembolization.

Citation: Chen MY, Juengpanich S, Hu JH, Topatana W, Cao JS, Tong CH, Lin J, Cai XJ. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma. World J Gastroenterol 2020; 26(10): 1042-1055
URL: https://www.wjgnet.com/1007-9327/full/v26/i10/1042.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i10.1042